NLM Digital Collections

Search

Start Over Subjects Humans ✖Remove constraint Subjects: Humans Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1622. Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Drugs, Generic -- economics
Drugs, Investigational -- economics
Investigational New Drug Application -- economics
Drug Approval -- economics
Humans
United States
United States. Food and Drug Administration.

1623. Physician workforce: locations and types of graduate training were largely unchanged, and federal efforts may not be sufficient to meet needs : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Education, Medical, Graduate -- statistics & numerical data
Health Manpower
Physicians, Family -- education
Physicians, Family -- supply & distribution
Primary Health Care -- manpower
Education, Medical, Graduate -- trends
Forecasting
Medicine -- statistics & numerical data
Nurse Practitioners -- supply & distribution
Physician Assistants -- supply & distribution
Rural Health Services -- manpower
Urban Health Services -- manpower
Humans
United States
United States. Department of Health and Human Services.

1624. VA information technology: pharmacy system needs additional capabilities for viewing, exchanging, and using data to better serve veterans : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Clinical Pharmacy Information Systems
Health Information Interoperability
Veterans Health
Veterans
Humans
United States
United States. Department of Defense.
United States. Department of Veterans Affairs.
United States. Veterans Health Administration.

1625. Veterans Affairs: improved management processes are necessary for it systems that better support health care : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Medical Informatics -- organization & administration
Veterans Health
Community Health Services
Health Services Accessibility
Health Services Needs and Demand
Insurance, Pharmaceutical Services
Humans
United States
United States. Veterans Health Administration

1626. Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Economics, Hospital
Quality of Health Care
Reimbursement, Incentive
Value-Based Purchasing
Hospitals, Rural -- economics
Hospitals, Urban -- economics
Safety-net Providers -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

1627. Gulf War illness: improvements needed for VA to better understand, process, and communicate decisions on claims : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Disability Evaluation
Persian Gulf Syndrome
Veterans
Veterans Disability Claims
Veterans Health
Insurance Claim Review
Humans
United States
United States. Department of Veterans Affairs.

1629. Medicaid expansion: behavioral health treatment use in selected states in 2014 : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Medicaid
Mental Disorders -- drug therapy
Mental Disorders -- therapy
Mental Health Services -- utilization
Analgesics, Opioid -- therapeutic use
Forecasting
Mental Health Services -- trends
Opioid-Related Disorders
Humans
Iowa
New York
Washington
West Virginia
United States
United States.

1630. Investigational new drugs: FDA has taken steps to improve the expanded access program but should further clarify how adverse events data are used : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):
Adverse Drug Reaction Reporting Systems
Drugs, Investigational -- adverse effects
Drugs, Investigational -- therapeutic use
Drug Approval
Health Services Accessibility
Humans
United States
United States. Food and Drug Administration.